Clinical Trials Directory

Trials / Completed

CompletedNCT04927832

Detection of Small Fiber Neuropathies by the Non-invasive SUDOSCAN Method During Chronic Autoimmune Pathologies and / or Unexplained Pain Syndromes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
139 (actual)
Sponsor
Hôpital Européen Marseille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Very few studies have evaluated the prevalence of small fiber neuropathy (SFN) during pathologies that may be responsible for small fibers damage. SUDOSCAN is a new rapid (2 minutes), automated, reproducible and non-invasive technology to assess small fiber neuropathy by sweat function. With quantitative and reproducible results, SUDOSCAN allows physicians to early detect and follow-up peripheral neuropathy to monitor disease progression and assess treatment efficacy for a better patient management. SUDOSCAN® could allow the identification of SFN in painful patients apart from another pathology already diagnosed responsible for SFN. The purpose of the study SUDOCU is to assess the prevalence of small fiber neuropathies (SFN) in patients with systemic autoimmune pathologies or unexplained pain syndrome.

Conditions

Interventions

TypeNameDescription
OTHERSUDOSCAN and EMG (electromyogram)The participants are evaluated clinically by a neurologist with evaluation by DN4 questionnaire, treatments and comorbidities (alcohol consumption, diabetes, etc.). They undergo from exploration by SUDOSCAN according to the already established methodology and an EMG

Timeline

Start date
2017-07-06
Primary completion
2023-02-23
Completion
2023-02-23
First posted
2021-06-16
Last updated
2025-09-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04927832. Inclusion in this directory is not an endorsement.